Symbol Lookup

Friday August 26, 2016 7:21 PM ET. Data delayed 15 minutes.
5.52
0.02 (0.36%)
Bid/Lots
5.26/30
Ask/Lots
5.95/10
Open/Prev Close
5.51/5.50
Day Range
5.41-5.69
52-Week Range
4.26-22.07
Vol/Avg Daily Vol
359.0K/539.0K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
How These Biotech Stocks are Faring? -- Progenics Pharma, Peregrine Pharma, Agios Pharma, and Cara Therapeutics
7 hours ago by PR Newswire
Companies Mentioned: PGNX, PPHM, AGIO, CARA

Stock-Callers.com has initiated research reports on the following Biotech companies: Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Agios Pharmaceuticals Inc. (NASDAQ: AGIO), and Cara Therapeutics Inc. (NASDAQ: CARA). On Wednesday, August 24, 2016, the iShares NASDAQ Biotechnology ETF (IBB) plummeted 3% after Democratic presidential candidate Hillary Clinton tweeted about the price hikes on EpiPens. Register now and get full and free access to our downloadable research reports on these stocks at:

Stock-Callers.com has initiated research reports on the following Biotech companies: Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Agios Pharmaceuticals Inc. (NASDAQ: AGIO), and Cara Therapeutics ...

Aug 24, 2016

Diversity of the Legal and Medical Marijuana Markets
12:00PM ET on Wednesday Aug 24, 2016 by PR Newswire
Companies Mentioned: TRTC, MJNA, FRLF, CARA, ZYNE

Legal U.S. marijuana sales reached $5.4 billion for 2015, which represents an increase of 17.4 percent from the $4.6 billion in 2014 according to ArcView Market Research. This year, even a bigger jump in sales is expected. As a result, more companies across the entire industry are trying their luck. What is more surprising is just how diverse the Cannabis industry is becoming. Freedom Leaf Inc. (OTC: FRLF), Medical Marijuana Inc (OTC: MJNA), Terra Tech Corp (OTCQX: TRTC), Cara Therapeutics Inc. (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE)

Legal U.S. marijuana sales reached $5.4 billion for 2015, which represents an increase of 17.4 percent from the $4.6 billion in 2014 according to ArcView Market Research. This year, even a bigger jump in sales is expected. As a result, more com...

Aug 23, 2016

The Growth of the Legal and Medical Marijuana Markets
9:57AM ET on Tuesday Aug 23, 2016 by PR Newswire
Companies Mentioned: TRTC, GWPH, CARA, ZYNE, VRTHF

The legal marijuana market in the United States is projected to grow substantially in 2016. A recent report by New Frontier and ArcView Market Research projected the marijuana market in the United States to grow to $7.1 billion in 2016, which represents a 26% growth comparing to 2015. Veritas Pharma Inc. (OTC: VRTHF), Cara Therapeutics Inc (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech Corp. (TRTC), GW Pharmaceuticals PLC (NASDAQ: GWPH)

The legal marijuana market in the United States is projected to grow substantially in 2016. A recent report by New Frontier and ArcView Market Research projected the marijuana market in the United States to grow to $7.1 billion in 2016, which r...

Aug 8, 2016

--Analyst Actions: Needham & Co Reiterates Cara Therapeutics Buy Rating; Lowers PT to $23 from $27
3:18PM ET on Monday Aug 08, 2016 by MT Newswires
Companies Mentioned: CARA
03:18 PM EDT, 08/08/2016 (MT Newswires) -- Price: 5.86, Change: -0.13, Percent Change: -2.17 ...
03:18 PM EDT, 08/08/2016 (MT Newswires) -- Price: 5.86, Change: -0.13, Percent Change: -2.17 ...

Aug 5, 2016

Cara Therapeutics to Webcast Presentation at Canaccord Genuity 36th Annual Growth Conference
8:00AM ET on Friday Aug 05, 2016 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the Canaccord Genuity 36 Annual Growth Conference on Thursday, August 11, 2016, at 12:30 p.m. ET in Boston.

Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced t...

← Newer12Older →

Peers Headlines

Aug 23, 2016

Close Update: U.S. Stocks Push Higher to Near Records as Oil Prices Reverse Losses
4:26PM ET on Tuesday Aug 23, 2016 by MT Newswires
Companies Mentioned: BSPM, KIRK, RAVN, ASTC, GPRE, STML, BBY, SPHS, ZOES, TKAI
04:26 PM EDT, 08/23/2016 (MT Newswires) -- A swing to gains in oil prices helped support the main U.S. stock indexes on Tuesday, with the Nasdaq Composite and the S&P 500 closing within a few points of last week's record highs, while 18 of the 30...
Midday Update: Wall Street Embraces Strong Home Sales, Rebound in Oil
12:49PM ET on Tuesday Aug 23, 2016 by MT Newswires
Companies Mentioned: BSPM, ASTC, TOL, STML, BBY, SPHS, ZOES, TKAI
12:49 PM EDT, 08/23/2016 (MT Newswires) -- Stocks have surrendered some of Tuesday morning's advance but are still maintaining modest gains as a result of an unexpected rebound in oil, strong home sales and strength in the technology sector that ...
BRIEF-Stemline Therapeutics expect to provide further updates around multiple SL-401
7:41AM ET on Tuesday Aug 23, 2016 by Thomson Reuters
Companies Mentioned: STML

Aug 23 (Reuters) - Stemline Therapeutics Inc

* Receives Breakthrough Therapy Designation From U.S. Food And Drug Administration For SL-401

* Expect to p...

Stemline Therapeutics Gets FDA Breakthrough Therapy Status for SL-401
7:31AM ET on Tuesday Aug 23, 2016 by MT Newswires
Companies Mentioned: STML
07:31 AM EDT, 08/23/2016 (MT Newswires) -- Stemline Therapeutics (STML) says the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to SL-401, a targeted therapy directed to the interleukin-3 receptor (CD123), to...
Stemline Therapeutics Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for SL-401
7:30AM ET on Tuesday Aug 23, 2016 by GlobeNewswire
Companies Mentioned: STML

Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to SL-401, a targeted therapy directed to the interleukin-3 receptor (CD123), for the treatm...

Aug 17, 2016

ProQR Therapeutics Q2 Loss Widens Vs Yr Ago as Revenues Slide
7:19AM ET on Wednesday Aug 17, 2016 by MT Newswires
Companies Mentioned: PRQR
07:19 AM EDT, 08/17/2016 (MT Newswires) -- ProQR Therapeutics (PRQR) reported pre-market Wednesday a Q2 loss of EUR0.43 ($0.48) per share, widening from a loss of EUR0.37 per share last year, which met the average estimate of two analysts for a l...
BRIEF-ProQR Therapeutics posts Q2 loss per share of 0.43 euros
7:17AM ET on Wednesday Aug 17, 2016 by Thomson Reuters
Companies Mentioned: PRQR

Aug 17 (Reuters) - ProQR Therapeutics NV

* Proqr announces results for the second quarter of 2016

* Q2 loss per share eur 0.43 Source text for Eikon: Fu...

Aug 11, 2016

Research Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences
8:40AM ET on Thursday Aug 11, 2016 by PR Newswire
Companies Mentioned: AGEN, VNDA, GNCA, DNAI

This morning on Stock-Callers.com we have Biotech industry under review. This segment is focused on new drug developments and clinical researches. Stocks under evaluation are: Agenus Inc. (NASDAQ: AGEN), ProNAi Therapeutics Inc. (NASDAQ: DNAI),...

Stemline Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference
7:00AM ET on Thursday Aug 11, 2016 by GlobeNewswire
Companies Mentioned: STML

Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 2016 Wedbush PacGrow Healthcare conference on Tuesday, August 16, 2016 at 3:40 PM ET. The conference will be held at the Le...

Aug 9, 2016

Genocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016's 40 Women To Watch Over 40 List
7:30AM ET on Tuesday Aug 09, 2016 by GlobeNewswire
Companies Mentioned: GNCA

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, is delighted to congratulate Jessica Baker Flechtner, Ph.D., chief scientific officer, who was acknowledged as an hono...

← Newer12Older →